These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2055819)
1. Penetration into tissues of various drugs active against gram-positive bacteria. Kropec A; Daschner FD J Antimicrob Chemother; 1991 Apr; 27 Suppl B():9-15. PubMed ID: 2055819 [TBL] [Abstract][Full Text] [Related]
2. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria]. Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380 [TBL] [Abstract][Full Text] [Related]
3. Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery. Frank UK; Schmidt-Eisenlohr E; Mlangeni D; Schindler M; Hoh A; Beyersdorf F; Daschner FD Antimicrob Agents Chemother; 1997 Nov; 41(11):2559-61. PubMed ID: 9371368 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients]. Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922 [No Abstract] [Full Text] [Related]
5. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile. Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341 [TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002]. Eta S; Kawahara M Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579 [TBL] [Abstract][Full Text] [Related]
7. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria. Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients. Sultan T; Baltch AL; Smith RP; Ritz W Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638 [TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ; Saravolatz LD; Somerville MM J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [TBL] [Abstract][Full Text] [Related]
12. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
14. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001]. Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872 [TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [TBL] [Abstract][Full Text] [Related]
16. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria. de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109 [TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children. Kline MW; Mason EO; Kaplan SL; Lamberth LB; Johnson GS J Antimicrob Chemother; 1987 Aug; 20(2):203-7. PubMed ID: 2822647 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources. Jensen KT; Schønheyder H; Pers C; Thomsen VF APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of dalbavancin in plasma and skin blister fluid. Nicolau DP; Sun HK; Seltzer E; Buckwalter M; Dowell JA J Antimicrob Chemother; 2007 Sep; 60(3):681-4. PubMed ID: 17631507 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol. Jones RN; Fritsche TR; Sader HS; Goldstein BP J Chemother; 2005 Dec; 17(6):593-600. PubMed ID: 16433188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]